切换至 "中华医学电子期刊资源库"
高级检索
中华危重症医学杂志(电子版)

中华危重症医学杂志(电子版) ›› 2022, Vol. 15 ›› Issue (01) : 28 -35. doi: 10.3877/cma.j.issn.1674-6880.2022.01.006

论著

体外膜肺氧合对心脏骤停患者神经功能预后的影响
金光勇1, 周梦露2, 刁孟元1, 席绍松1, 曾小康1, 顾乔1, 朱英1, 胡炜1,†()   
  1. 1. 310006　杭州，浙江大学医学院附属杭州市第一人民医院重症医学科
    2. 310015　杭州，杭州师范大学附属医院神经内科
  • 收稿日期:2021-07-28 出版日期:2022-02-28
  • 通信作者: 胡炜
  • 基金资助:
    浙江省医药卫生科技计划项目(2019KY481); 杭州市医学重点学科建设基金项目(OO20200485)

Effect of extracorporeal membrane oxygenation on the prognosis of neurological function in patients with cardiac arrest

Guangyong Jin1, Menglu Zhou2, Mengyuan Diao1, Shaosong Xi1, Xiaokang Zeng1, Qiao Gu1, Ying Zhu1, Wei Hu1,†()   

  1. 1. Department of Intensive Care Unit, the Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou 310006, China
    2. Department of Neurology, the Affiliated Hospital of Hangzhou Normal University, Hangzhou 310015, China
  • Received:2021-07-28 Published:2022-02-28
  • Corresponding author: Wei Hu
全文 ( ) 下载PDF ( ) 导出引用
引用本文：

金光勇, 周梦露, 刁孟元, 席绍松, 曾小康, 顾乔, 朱英, 胡炜. 体外膜肺氧合对心脏骤停患者神经功能预后的影响[J/OL]. 中华危重症医学杂志(电子版), 2022, 15(01): 28-35.

Guangyong Jin, Menglu Zhou, Mengyuan Diao, Shaosong Xi, Xiaokang Zeng, Qiao Gu, Ying Zhu, Wei Hu. Effect of extracorporeal membrane oxygenation on the prognosis of neurological function in patients with cardiac arrest[J/OL]. Chinese Journal of Critical Care Medicine(Electronic Edition), 2022, 15(01): 28-35.

目的

探讨体外膜肺氧合（ECMO）对心脏骤停患者神经功能预后的影响因素。

方法

纳入2012年1月至2020年6月因心脏骤停入住浙江大学医学院附属杭州市第一人民医院重症医学科且行ECMO治疗的22例患者。以脑功能分类（CPC）量表评价患者出院时神经功能情况，并将其分为CPC良好组（12例，CPC 1 ~ 2分）和CPC不佳组（10例，CPC 3 ~ 5分）。比较两组患者的一般资料、心脏骤停病因、基础疾病、疾病严重程度、心脏骤停相关情况、神经系统相关情况、ECMO相关情况及肌钙蛋白I、白蛋白等生化指标。采用二分类Logistic回归分析ECMO治疗心脏骤停患者对其神经功能预后的影响因素。

结果

22例接受ECMO治疗的心脏骤停患者中，14例存活出院且12例神经功能良好。CPC不佳组患者肌钙蛋白I[47.0（26.8，80.0）μg/L vs. 13.6（3.3，32.6）μg/L，U = 20.000，P = 0.017]水平较CPC良好组显著升高，白蛋白[（27 ± 7）g/L vs.（33 ± 6）g/L，t = 2.485，P = 0.022]水平较CPC良好组显著降低。此外，CPC不佳组患者第3天ECMO流量[（3.6 ± 0.8）L/min vs.（3.0 ± 0.7）L/min，t = 2.091，P = 0.050]高于CPC良好组，但两组比较差异无统计学意义。Logistic回归分析结果显示，较低的白蛋白浓度[优势比（OR）= 0.755，95%置信区间（CI）（0.576，0.990），P = 0.042]是ECMO治疗心脏骤停患者神经功能预后不佳的独立危险因素。

结论

较低的白蛋白浓度是ECMO治疗的心脏骤停患者神经功能预后不佳的独立危险因素。

关键词: 心脏骤停, 体外膜肺氧合, 白蛋白
Objective

To explore the influencing factors of extracorporeal membrane oxygenation (ECMO) on the prognosis of neurological function in patients with cardiac arrest (CA).

Methods

A total of 22 patients with CA who were treated with ECMO in the Department of Intensive Care Unit, the Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine from January 2012 to June 2020 were included. After evaluating the cerebral performance category (CPC) scale at discharge, we divided the participants into two groups: 12 cases in the good CPC group (CPC 1-2) and 10 cases in the poor CPC group (CPC 3-5). The general information, causes of CA, underlying diseases, disease severity, CA related conditions, nervous system related conditions, ECMO related conditions, troponin I, albumin and other biochemical indicators were compared between the two groups. Then with binary Logistic regression analysis, we assessed the possible influencing factors of ECMO on the prognosis of neurological function in participants.

Results

Of the 22 CA patients treated with ECMO, 14 were alive at discharge and among them 12 were alive with good neurological function. The poor CPC group has a significantly higher level of troponin I [47.0 (26.8, 80.0) μg/L vs. 13.6 (3.3, 32.6) μg/L, U = 20.000, P = 0.017], and a lower level of albumin [(27 ± 7) g/L vs. (33 ± 6) g/L, t = 2.485, P = 0.022] comparing with the good CPC group. Though the flow rate on the third day of ECMO was higher in the poor CPC group, there was no statistically significant difference between two groups [(3.6 ± 0.8) L/min vs. (3.0 ± 0.7) L/min, t = 2.091, P = 0.050]. In addition, the Logistic regression analysis showed that lower albumin concentration was an independent risk factor for poor neurological prognosis in patients with CA after ECMO treatment [odds ratio (OR) = 0.755, 95% confidence interval (CI) (0.576, 0.990), P = 0.042].

Conclusion

In present study, we found lower albumin concentration was an independent risk factor for poor neurological prognosis in patients with CA after ECMO treatment.

Key words: Cardiac arrest, Extracorporeal membrane oxygenation, Albumin
表1 两组心脏骤停患者一般资料比较（ ± s）
组别 例数 年龄[岁，M（P25，P75）] 性别（例，男/女） 心脏骤停病因（例） 基础情况（例） 病情严重程度（分）
急性心肌梗死 爆发性心肌炎 其他病因 高血压 糖尿病 CHD 慢性肾病 抽烟 APACHE Ⅱ评分 SOFA评分
CPC良好组 12 37.5（27.0，40.0） 5/7 5 6 1 3 2 1 0 1 21 ± 10 11.5 ± 2.5
CPC不佳组 10 62.5（28.0，67.8） 7/3 7 3 0 5 2 2 1 1 25 ± 10 13.8 ± 5.0
t/χ2/U值   45.000 - 2.169 - - - - - 0.829 1.390
P值   0.339 0.231 0.338 0.378 1.000 0.571 0.455 1.000 0.417 0.180
表2 两组心脏骤停患者临床资料比较[M（P25，P75）]
组别 例数 心脏骤停相关情况（例） 神经系统相关情况（例）
发生在医院内 发生在医院外 旁观者心肺复苏 可电击心律 ECMO前ROSC ROSC后再次心脏骤停 0 h意识-昏迷 72 h意识-昏迷 0 h瞳孔直径（mm） 72 h瞳孔直径（mm）
CPC良好组 12 11 1 12 11 9 11 9 5 2.5（1.6，4.8） 2.0（1.5，2.0）
CPC不佳组 10 8 2 7 9 8 6 8 7 2.3（1.4，3.9） 2.0（1.4，2.9）
t/χ2/U值   - - - - - - - 50.000 56.000
P值   0.571 0.078 1.000 1.000 0.135 1.000 0.231 0.525 0.811
组别 例数 ECMO相关情况
建立ECMO耗时（min） ECMO后体温（℃） ECMO后脉搏（次/min） ECMO后呼吸频率（次/min） ECMO后平均动脉压（mmHg） 初始流量（L/min） 第1天流量（L/min） 第2天流量（L/min） 第3天流量（L/min） ECMO运行时间（d）
CPC良好组 12 55.0（42.5，69.8） 36.1（35.6，36.6） 83 ± 34 15.0（15.0，16.0） 94.5（69.0，99.8） 3.4 ± 0.8 3.3（3.0，3.8） 3.4 ± 0.8 3.0 ± 0.7 6.0（5.0，8.0）
CPC不佳组 10 49.0（43.8，71.5） 36.0（35.7，36.8） 110 ± 58 15.0（12.8，16.0） 85.5（70.8，100.0） 3.5 ± 0.8 3.2（3.0，3.7） 3.6 ± 0.9 3.6 ± 0.8 7.0（5.8，11.8）
t/χ2/U值   56.500 56.500 1.296 54.500 56.500 0.203 55.500 0.629 2.091 41.000
P值   0.843 0.842 0.218 0.731 0.843 0.840 0.792 0.536 0.050 0.217
组别 例数 并发症情况（例） 其他相关情况 检验指标
腹腔/消化道出血 下肢缺血 脓毒症 使用CRRT（例） 使用IABP（例） 有创机械通气时间（d） 使用去甲肾上腺素（例） pH值 乳酸（mmol/L） 24 h乳酸清除率（%）
CPC良好组 12 1 0 0 8 5 9±6 9 7.34（7.22，7.50） 9 ± 6 59 ± 28
CPC不佳组 10 3 3 2 9 6 14 ± 6 7 7.41（7.29，7.45） 8 ± 6 38 ± 43
t/χ2/U值   - - - - - 2.041 - 57.000 0.294 1.390
P值   0.293 0.078 0.195 0.323 0.670 0.054 1.000 0.869 0.772 0.180
组别 例数 检验指标
肌钙蛋白I（μg/L） 总胆红素（μmol/L） 肌酐（μmol/L） 白蛋白（g/L） 血糖（mmol/L） 血钠（mmol/L） 白细胞计数（× 109/L） 血红蛋白（g/L） 血小板计数（× 109/L） 凝血酶原时间（s）
CPC良好组 12 13.6（3.3，32.6） 18.8（13.2，33.0） 117.5（107.0，169.8） 33 ± 6 13.4（8.3，14.6） 144 ± 6 17 ± 6 109 ± 24 176±87 16.4（15.2，21.7）
CPC不佳组 10 47.0（26.8，80.0） 17.8（11.9，26.7） 112.5（102.3，193.3） 27 ± 7 12.4（10.6，16.1） 146 ± 5 15 ± 6 106 ± 28 169±91 24.9（14.6，41.3）
t/χ2/U值   20.000 55.000 58.000 2.485 59.000 0.738 0.756 0.187 0.171 37.000
P值   0.017 0.767 0.921 0.022 0.974 0.469 0.459 0.854 0.865 0.138
表3 影响ECMO治疗心脏骤停患者神经功能预后的Logistic回归分析
变量 回归系数 标准误 Wald值 P值 OR值 95%CI
肌钙蛋白I（μg/L） 0.005 0.012 0.149 0.700 1.005 0.982 ~ 1.028
白蛋白（g/L） -0.281 0.138 4.132 0.042 0.755 0.576 ~ 0.990
1
Gu XM, Yao SB, He ZJ, et al. Meta-analysis of the success rate of heartbeat recovery in patients with prehospital cardiac arrest in the past 40 years in China[J]. Mil Med Res, 2020, 7 (1): 34.
2
寇卜今，陈碧华，廖雪丽，等.气管内插管与声门上气道放置对院外心脏骤停患者心肺复苏疗效的Meta分析[J/CD].中华危重症医学杂志（电子版），2019，12（3）：163-168.
3
Peberdy MA, Kaye W, Ornato JP, et al. Cardiopulmonary resuscitation of adults in the hospital: a report of 14,720 cardiac arrests from the National Registry of Cardiopulmonary Resuscitation[J]. Resuscitation, 2003, 58 (3): 297-308.
4
Daya MR, Schmicker RH, Zive DM, et al. Out-of-hospital cardiac arrest survival improving over time: results from the Resuscitation Outcomes Consortium (ROC)[J]. Resuscitation, 2015 (91): 108-115.
5
Rea TD, Eisenberg MS, Becker LJ, et al. Temporal trends in sudden cardiac arrest: a 25-year emergency medical services perspective[J]. Circulation, 2003, 107 (22): 2780-2785.
6
Richardson AS, Schmidt M, Bailey M, et al. ECMO Cardio-Pulmonary Resuscitation (ECPR), trends in survival from an international multicentre cohort study over 12-years[J]. Resuscitation, 2017 (112): 34-40.
7
Siao FY, Chiu CC, Chiu CW, et al. Managing cardiac arrest with refractory ventricular fibrillation in the emergency department: conventional cardiopulmonary resuscitation versus extracorporeal cardiopulmonary resuscitation[J]. Resuscitation, 2015 (92): 70-76.
8
邱方方，陆远强.生命的桥梁——体外膜肺氧合在心脏骤停中的应用[J/CD].中华危重症医学杂志（电子版），2019，12（4）：217-222.
9
Daou O, Winiszewski H, Besch G, et al. Initial pH and shockable rhythm are associated with favorable neurological outcome in cardiac arrest patients resuscitated with extracorporeal cardiopulmonary resuscitation[J]. J Thorac Dis, 2020, 12 (3): 849-857.
10
Dennis M, Zmudzki F, Burns B, et al. Cost effectiveness and quality of life analysis of extracorporeal cardiopulmonary resuscitation (ECPR) for refractory cardiac arrest[J]. Resuscitation, 2019 (139): 49-56.
11
中华医学会，中华医学会杂志社，中华医学会全科医学分会，等.心脏骤停基层诊疗指南（2019年）[J].中华全科医师杂志，2019，18（11）：1034-1041.
12
Soar J, Maconochie I, Wyckoff MH, et al. 2019 international consensus on cardiopulmonary resuscitation and emergency cardiovascular care science with treatment recommendations: summary from the basic life support; advanced life support; pediatric life support; neonatal life support; education, implementation, and teams; and first aid task forces[J]. Circulation, 2019, 140 (24): e826-e880.
13
Kleinman ME, Goldberger ZD, Rea T, et al. 2017 American Heart Association focused update on adult basic life support and cardiopulmonary resuscitation quality: an update to the American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care[J]. Circulation, 2018, 137 (1): e7-e13.
14
中华医学会急诊医学分会复苏学组，成人体外心肺复苏专家共识组.成人体外心肺复苏专家共识[J].中华急诊医学杂志，2018，27（1）：22-29.
15
中国医师协会体外生命支持专业委员会.成人体外膜氧合循环辅助专家共识[J].中华医学杂志，2018，98（12）：886-894.
16
Michels G, Wengenmayer T, Hagl C, et al. Recommendations for extracorporeal cardiopulmonary resuscitation (eCPR): consensus statement of DGIIN, DGK, DGTHG, DGfK, DGNI, DGAI, DIVI and GRC[J]. Med Klin Intensivmed Notfmed, 2018, 113 (6): 478-486.
17
Medicherla CB, Lewis A. The critically ill brain after cardiac arrest[J]. Ann N Y Acad Sci, 2020, 1507 (1): 12-22.
18
Lunz D, Calabrò L, Belliato M, et al. Extracorporeal membrane oxygenation for refractory cardiac arrest: a retrospective multicenter study[J]. Intensive Care Med, 2020, 46 (5): 973-982.
19
Ryu JA, Cho YH, Sung K, et al. Predictors of neurological outcomes after successful extracorporeal cardiopulmonary resuscitation[J]. BMC Anesthesiol, 2015 (15): 26.
20
Axtell AL, Funamoto M, Legassey AG, et al. Predictors of neurologic recovery in patients who undergo extracorporeal membrane oxygenation for refractory cardiac arrest[J]. J Cardiothorac Vasc Anesth, 2020, 34 (2): 356-362.
21
Siao FY, Chiu CW, Chiu CC, et al. Can we predict patient outcome before extracorporeal membrane oxygenation for refractory cardiac arrest?[J]. Scand J Trauma Resusc Emerg Med, 2020, 28 (1): 58.
22
Tonna JE, Selzman CH, Mallin MP, et al. Development and implementation of a comprehensive, multidisciplinary emergency department extracorporeal membrane oxygenation program[J]. Ann Emerg Med, 2017, 70 (1): 32-40.
23
Patricio D, Peluso L, Brasseur A, et al. Comparison of extracorporeal and conventional cardiopulmonary resuscitation: a retrospective propensity score matched study[J]. Crit Care, 2019, 23 (1): 27.
24
Yannopoulos D, Bartos JA, Martin C, et al. Minnesota Resuscitation Consortium's advanced perfusion and reperfusion cardiac life support strategy for out-of-hospital refractory ventricular fibrillation[J]. J Am Heart Assoc, 2016, 5 (6): e003732.
25
Wang J, Ma Q, Zhang H, et al. Predictors of survival and neurologic outcome for adults with extracorporeal cardiopulmonary resuscitation: a systemic review and meta-analysis[J]. Medicine (Baltimore), 2018, 97 (48): e13257.
26
Lin JW, Wang MJ, Yu HY, et al. Comparing the survival between extracorporeal rescue and conventional resuscitation in adult in-hospital cardiac arrests: propensity analysis of three-year data[J]. Resuscitation, 2010, 81 (7): 796-803.
27
Debaty G, Babaz V, Durand M, et al. Prognostic factors for extracorporeal cardiopulmonary resuscitation recipients following out-of-hospital refractory cardiac arrest. A systematic review and meta-analysis[J]. Resuscitation, 2017 (112): 1-10.
28
Bouglé A, Le Gall A, Dumas F, et al. ExtraCorporeal life support for cardiac ARrest in patients with post cardiac arrest syndrome: the ECCAR study[J]. Arch Cardiovasc Dis, 2019, 112 (4): 253-260.
29
Yukawa T, Kashiura M, Sugiyama K, et al. Neurological outcomes and duration from cardiac arrest to the initiation of extracorporeal membrane oxygenation in patients with out-of-hospital cardiac arrest: a retrospective study[J]. Scand J Trauma Resusc Emerg Med, 2017, 25 (1): 95.
30
Okada Y, Kiguchi T, Irisawa T, et al. Association between low pH and unfavorable neurological outcome among out-of-hospital cardiac arrest patients treated by extracorporeal CPR: a prospective observational cohort study in Japan[J]. J Intensive Care, 2020 (8): 34.
31
Iesu E, Franchi F, Zama Cavicchi F, et al. Acute liver dysfunction after cardiac arrest[J]. PLoS One, 2018, 13 (11): e0206655.
32
Ortuno S, Delmas C, Diehl JL, et al. Weaning from veno-arterial extra-corporeal membrane oxygenation: which strategy to use?[J]. Ann Cardiothorac Surg, 2019, 8 (1): E1-E8.
33
Cevasco M, Takayama H, Ando M, et al. Left ventricular distension and venting strategies for patients on venoarterial extracorporeal membrane oxygenation[J]. J Thorac Dis, 2019, 11 (4): 1676-1683.
34
Mebazaa A, Combes A, van Diepen S, et al. Management of cardiogenic shock complicating myocardial infarction[J]. Intensive Care Med, 2018, 44 (6): 760-773.
35
Aissaoui N, Guerot E, Combes A, et al. Two-dimensional strain rate and Doppler tissue myocardial velocities: analysis by echocardiography of hemodynamic and functional changes of the failed left ventricle during different degrees of extracorporeal life support[J]. J Am Soc Echocardiogr, 2012, 25 (6): 632-640.
36
Fried JA, Masoumi A, Takeda K, et al. How I approach weaning from venoarterial ECMO[J]. Crit Care, 2020, 24 (1): 307.
37
Pearson DA, Wares CM, Mayer KA, et al. Troponin marker for acute coronary occlusion and patient outcome following cardiac arrest[J]. West J Emerg Med, 2015, 16 (7): 1007-1013.
38
Rosjo H, Vaahersalo J, Hagve TA, et al. Prognostic value of high-sensitivity troponin T levels in patients with ventricular arrhythmias and out-of-hospital cardiac arrest: data from the prospective FINNRESUSCI study[J]. Crit Care, 2014, 18 (6): 605.
39
Isenschmid C, Kalt J, Gamp M, et al. Routine blood markers from different biological pathways improve early risk stratification in cardiac arrest patients: Results from the prospective, observational COMMUNICATE study[J]. Resuscitation, 2018 (130): 138-145.
40
Matsuyama T, Iwami T, Yamada T, et al. Effect of serum albumin concentration on neurological outcome after out-of-hospital cardiac arrest (from the critical [comprehensive registry of intensive cares for OHCA survival] study in Osaka, Japan)[J]. Am J Cardiol, 2018, 121 (2): 156-161.
41
Taverna M, Marie AL, Mira JP, et al. Specific antioxidant properties of human serum albumin[J]. Ann Intensive Care, 2013, 3 (1): 4.
42
Nicholson JP, Wolmarans MR, Park GR. The role of albumin in critical illness[J]. Br J Anaesth, 2000, 85 (4): 599-610.
43
Manole MD, Kochanek PM, Foley LM, et al. Polynitroxyl albumin and albumin therapy after pediatric asphyxial cardiac arrest: effects on cerebral blood flow and neurologic outcome[J]. J Cereb Blood Flow Metab, 2012, 32 (3): 560-569.
[1] 张秋阳, 余韶芸, 潘向滢, 金家佳, 夏桦, 赵雪红. 成年体外膜肺氧合患者出血影响因素的Meta 分析[J/OL]. 中华危重症医学杂志(电子版), 2024, 17(05): 392-398.
[2] 丁丁, 杨云川, 马翔, 马中正, 霍俊一, 周磊. 术前C-反应蛋白-白蛋白-淋巴细胞比值在肝细胞癌预后中的价值评估[J/OL]. 中华普通外科学文献(电子版), 2024, 18(04): 261-265.
[3] 霍枫, 李智霞, 季茹, 谭晓宇, 范晓礼, 叶啟发. 以循环标准判定死亡的遗体器官捐献分类标准、实施流程及需要注意的问题[J/OL]. 中华移植杂志(电子版), 2024, 18(04): 213-221.
[4] 王石林, 叶继章, 丘向艳, 陈桂青, 邹晓敏. 慢性阻塞性肺疾病真菌感染风险早期预测分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 773-776.
[5] 张怡, 王宇洋, 司梦娇, 曹燕, 李欢欢. 脑卒中前白蛋白与肺炎发生风险相关性分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(04): 648-651.
[6] 关小玲, 周文营, 陈洪平. PTAAR在乙肝相关慢加急性肝衰竭患者短期预后中的预测价值[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 841-845.
[7] 伍细蓉, 徐立文, 陈亚琼. 基于LPR和FARI构建肝衰竭患者生存预后模型[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 675-681.
[8] 张少青, 吕玉风, 董海霞. 中性粒细胞百分比/白蛋白比值对维持性血液透析患者全因死亡的预测作用[J/OL]. 中华肾病研究电子杂志, 2024, 13(06): 321-326.
[9] 王晓霞, 乌丹, 张江英, 乌雅罕, 郝颖楠, 斯日古楞. 《2023 年美国胸科学会关于成人急性呼吸窘迫综合征患者管理的临床实践指南更新》解读[J/OL]. 中华重症医学电子杂志, 2024, 10(04): 338-343.
[10] 孙文恺, 沈青, 杭丽, 张迎春. 纤维蛋白原与清蛋白比值、中性粒细胞与白蛋白比值、C反应蛋白与溃疡性结肠炎病情评估和预后的关系[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(05): 426-431.
[11] 周庆, 杨旭. 甲胎蛋白、纤维蛋白原与前白蛋白比值、癌胚抗原、D-二聚体对结肠癌术后复发的预测价值[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(04): 301-305.
[12] 赵文元, 田玉廷, 张吉海, 张军. CT肿瘤体积测量参数结合实验室指标对结肠癌术前分期预判的价值[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(04): 306-309.
[13] 唐成鑫, 亢文超, 孙玉芳, 项涛, 马林. 成都市院前急救中心院外心脏骤停的调度流程及改进措施分析[J/OL]. 中华临床医师杂志(电子版), 2024, 18(08): 745-750.
[14] 郭子宾, 柯学锋, 余琳潇, 张伟艺, 张军, 汪娟. 2015年至2019年盐田区院外心脏骤停患者救治成功的影响因素分析和应对策略[J/OL]. 中华卫生应急电子杂志, 2024, 10(04): 199-202.
[15] 刘晴雯, 韩勇, 陈丽丹, 邓哲. 早期机械通气对成人院内心脏骤停病死率的影响：一项回顾性队列研究[J/OL]. 中华卫生应急电子杂志, 2024, 10(04): 203-206.
阅读次数
全文


摘要

版权所有 中华医学会 中华医学电子音像出版社有限责任公司  京ICP备14006079号-1  网络出版服务许可证：(署)网出证(京)字第075号